Research ArticleArticle
Midazolam Oxidation by Cytochrome P450 3A4 and Active-Site Mutants: an Evaluation of Multiple Binding Sites and of the Metabolic Pathway That Leads to Enzyme Inactivation
Kishore K. Khan, You Qun He, Tammy L. Domanski and James R. Halpert
Molecular Pharmacology March 2002, 61 (3) 495-506; DOI: https://doi.org/10.1124/mol.61.3.495
Kishore K. Khan
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas.
You Qun He
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas.
Tammy L. Domanski
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas.
James R. Halpert
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas.

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Midazolam Oxidation by Cytochrome P450 3A4 and Active-Site Mutants: an Evaluation of Multiple Binding Sites and of the Metabolic Pathway That Leads to Enzyme Inactivation
Kishore K. Khan, You Qun He, Tammy L. Domanski and James R. Halpert
Molecular Pharmacology March 1, 2002, 61 (3) 495-506; DOI: https://doi.org/10.1124/mol.61.3.495
Research ArticleArticle
Midazolam Oxidation by Cytochrome P450 3A4 and Active-Site Mutants: an Evaluation of Multiple Binding Sites and of the Metabolic Pathway That Leads to Enzyme Inactivation
Kishore K. Khan, You Qun He, Tammy L. Domanski and James R. Halpert
Molecular Pharmacology March 1, 2002, 61 (3) 495-506; DOI: https://doi.org/10.1124/mol.61.3.495
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement